Business Description
Shandong Sinobioway Biomedicine Co Ltd
NAICS : 325998
SIC : 2899
ISIN : CNE1000012Y5
Share Class Description:
SZSE:002581: Class ACompare
Compare
Traded in other countries / regions
002581.China IPO Date
2011-05-20Description
Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.69 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -18.52 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 18.37 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.3 | |||||
| 3-Year EBITDA Growth Rate | -17.9 | |||||
| 3-Year Book Growth Rate | 0.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.64 | |||||
| 9-Day RSI | 51.64 | |||||
| 14-Day RSI | 52.43 | |||||
| 6-1 Month Momentum % | -27.58 | |||||
| 12-1 Month Momentum % | -41.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 1.22 | |||||
| Days Inventory | 411.99 | |||||
| Days Sales Outstanding | 141.3 | |||||
| Days Payable | 199.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.42 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.95 | |||||
| Operating Margin % | -27.07 | |||||
| Net Margin % | -11.77 | |||||
| FCF Margin % | -10.02 | |||||
| ROE % | -2.07 | |||||
| ROA % | -1.76 | |||||
| ROIC % | -8.75 | |||||
| ROC (Joel Greenblatt) % | -0.79 | |||||
| ROCE % | -0.25 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 45.04 | |||||
| PS Ratio | 19.79 | |||||
| PB Ratio | 3.45 | |||||
| Price-to-Tangible-Book | 3.62 | |||||
| EV-to-EBIT | -1271.34 | |||||
| EV-to-EBITDA | -1271.34 | |||||
| EV-to-Revenue | 19.3 | |||||
| EV-to-FCF | -190.87 | |||||
| Price-to-Projected-FCF | 5.71 | |||||
| Price-to-Median-PS-Value | 1.38 | |||||
| Price-to-Net-Current-Asset-Value | 28.66 | |||||
| Earnings Yield (Greenblatt) % | -0.08 | |||||
| FCF Yield % | -0.51 | |||||
| Forward Rate of Return (Yacktman) % | -9.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Sinobioway Biomedicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 419.898 | ||
| EPS (TTM) (Â¥) | -0.075 | ||
| Beta | 1.28 | ||
| Volatility % | 43.93 | ||
| 14-Day RSI | 52.43 | ||
| 14-Day ATR (Â¥) | 0.499239 | ||
| 20-Day SMA (Â¥) | 12.7205 | ||
| 12-1 Month Momentum % | -41.88 | ||
| 52-Week Range (Â¥) | 8.54 - 21.69 | ||
| Shares Outstanding (Mil) | 659.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Sinobioway Biomedicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Sinobioway Biomedicine Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Sinobioway Biomedicine Co Ltd Frequently Asked Questions
What is Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581)'s stock price today?
The current price of SZSE:002581 is ¥12.61. The 52 week high of SZSE:002581 is ¥21.69 and 52 week low is ¥8.54.
When is next earnings date of Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581)?
The next earnings date of Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) is .
Does Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) pay dividends? If so, how much?
Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers